RFP
GMAB icon

Root Financial Partners’s Genmab GMAB Stock Holding History

Root Financial Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$805 Buy
30
+8
+36% +$240 ﹤0.01% 2683
2025
Q4 		$678 Buy
22
+17
+340% +$530 ﹤0.01% 2171
2025
Q3 		$153 Buy
+5
New +$122 ﹤0.01% 2220

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Root Financial Partners's GMAB Position: Q1 2026 in Review

Root Financial Partners increased its Genmab (GMAB) stake by 36% in Q1 2026, buying an estimated $240 and bringing the position to 30 shares worth $805. The position accounts for ﹤0.01% of the portfolio, ranked #2683.

Root Financial Partners first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Root Financial Partners held 30 shares of Genmab worth $805 as of Q1 2026.
  • Root Financial Partners bought 8 Genmab shares in Q1 2026, an estimated $240.
  • Genmab made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2683 holding.
  • Root Financial Partners first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.